Search

everythinglearnresearchcommunity

for

Search:↓

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Some people with chronic hair loss may have thyroid autoimmunity.

Low vitamin D levels may be linked to early hair loss in males.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

High androgen levels cause skin issues in PCOS, affecting quality of life.

Early treatment of PCOS is crucial for better health and quality of life.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Most men stopped using the hair loss treatment not because of sexual side effects, but because they didn't see positive results.

Androgenetic alopecia slightly affects quality of life but can significantly impact self-esteem and social interactions for some.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Smoking increases the risk and severity of male pattern baldness.

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

Micrografts are a safe and effective treatment for hair loss in both men and women.